|Articles|May 2, 2017
WIRB-Copernicus Group Acquires ThreeWire
WIRB-Copernicus Group announces the acquisition of ThreeWire.
Advertisement
WIRB-Copernicus Group announces the acquisition of ThreeWire, a global patient recruitment, enrollment and retention firm that assists biopharma, medical device companies and CROs achieve trial enrollment and retention goals.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
3
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
4
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
